Key result
A 3-lncRNA risk score independently predicts survival in patients with liver hepatocellular carcinoma.
Why the study?
Hepatocellular carcinoma is typically diagnosed at late stages, creating an urgent need for more effective biomarkers for early diagnosis and prognostic prediction.
Does a 3-lncRNA-based risk score model predict survival in patients with hepatocellular carcinoma?
Population
371 tumor samples of liver hepatocellular carcinoma from TCGA
Design
Bioinformatic single-sample network and prognostic modeling study
Authors
Loading...
Supports lncRNA-based risk scoring for HCC prognosis; leaves open clinical adoption pending prospective validation.
Observational (n=371)
Does a 3-lncRNA-based risk score model predict survival in patients with hepatocellular carcinoma?
A novel 3-lncRNA-based risk score model was identified as an independent predictor for survival in patients with hepatocellular carcinoma.
Yu et al. (2020) conducted an observational in Liver hepatocellular carcinoma (n=371). 3-lncRNA-based risk score was evaluated on Survival. A 3-lncRNA-based risk score was identified as an independent predictor for survival in patients with liver hepatocellular carcinoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: